|
In these two 6-week studies of Elidel, the combined efficacy results at endpoint are a Text Continues Below
s
follows:
% Patients
Elidel® Vehicle
(N= 267) (N= 136)
Global Assessment
Clear 28 (10%) 5 ( 4%)
Clear or Almost Clear 93 (35%) 25 (18%)
Clear to Mild Disease 180 (67%) 55 (40%) In the two pediatric studies that independently support the use of Elidel Cream in mild to moderate atopic dermatitis, a significant treatment effect was seen by day 15. Of the key signs of atopic dermatitis, erythema, infiltration/papulation, lichenification, and excoriations, erythema and infiltration/papulation were reduced at day 8 when compared to vehicle.
The following graph depicts the time course of improvement in the percent body surface area affected as a result of treatment with Elidel Cream in 2-17 year olds.
The following graph shows the time course of improvement in erythema as a result of treatment with Elidel Cream in 2-17 year olds.
Page: << Prev | 1 | 2 | 3 | 4
|
.gif)
